아르테미신산시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 부문별 : 유형별(전합성, 반합성), 용도별(항말라리아 주사제, 항말라리아 정제), 지역별 세분화 및 경쟁 구도(2020-2030년)
Artemisinic Acid Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Total Synthesis, Semi synthesis), By Applications (Antimalarial Injections, Antimalarial Tablets), By Region, By Competition, 2020-2030F
상품코드:1879345
리서치사:TechSci Research
발행일:2025년 11월
페이지 정보:영문 183 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 아르테미신산시장은 2024년에 5억 2,190만 달러로 평가되었고, 2030년까지 연평균 복합 성장률(CAGR) 4.11%로 성장하여 6억 6,457만 달러에 이를 것으로 예측됩니다.
아르테미신산은 주로 *Artemisia annua L.*(쑥)에서 추출되는 중요한 세스 퀴 테르펜으로, 항말라리아 약품에 필수적인 활성 성분인 아르테미시닌의 반합성에서 중요한 전구체 역할을 합니다. 이 시장의 확대는 몇 가지 주요 촉진요인에 의해 강력하게 뒷받침되고 있습니다. 여기에는 아르테미시닌 복합요법(ACT)에 대한 수요를 지속시키는 전 세계적인 말라리아의 확산과 미생물 발효와 같은 생명공학 생산 기술의 지속적인 발전이 포함됩니다. 이러한 발전은 공급망의 신뢰성과 비용 예측 가능성을 향상시킬 수 있습니다. 또한, 말라리아 이외의 다양한 치료 용도를 모색하는 연구개발에 대한 투자 증가도 시장 성장에 기여하고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
5억 2,190만 달러
시장 규모 : 2030년
6억 6,457만 달러
CAGR : 2025-2030년
4.11%
성장 속도가 가장 빠른 부문
항말라리아 정제
최대 시장
중동 및 아프리카
주요 시장 성장 촉진요인
주요 시장 과제
주요 시장 동향
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 아르테미신산 시장 전망
시장 규모와 예측
금액별
시장 점유율과 예측
유형별(전합성, 반합성)
용도별(항말라리아 주사제, 항말라리아 정제)
지역별
기업별(2024년)
시장 맵
제6장 북미의 아르테미신산 시장 전망
시장 규모와 예측
시장 점유율과 예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 아르테미신산 시장 전망
시장 규모와 예측
시장 점유율과 예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 아르테미신산 시장 전망
시장 규모와 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 아르테미신산 시장 전망
시장 규모와 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트(UAE)
남아프리카공화국
제10장 남미의 아르테미신산 시장 전망
시장 규모와 예측
시장 점유율과 예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
인수합병(M&A)
제품 출시
최근 동향
제13장 세계의 아르테미신산 시장 : SWOT 분석
제14장 Porter의 Five Forces 분석
업계내 경쟁
신규 참여 가능성
공급업체의 힘
고객의 힘
대체품의 위협
제15장 경쟁 구도
Sanofi SA
KPC Pharmaceuticals, Inc
Guilin Pharmaceutical Co., Ltd
Calyx Chemicals and Pharmaceuticals Ltd.
Novartis AG
Ipca Laboratories Ltd.
Cipla Inc.
Shin Poong Pharm Co., Ltd.
Rupus Global Limited
AdvacarePharma
제16장 전략적 제안
제17장 회사 소개 및 면책조항
LSH
영문 목차
영문목차
The Global Artemisinic Acid Market, valued at USD 521.9 Million in 2024, is projected to experience a CAGR of 4.11% to reach USD 664.57 Million by 2030. Artemisinic acid, a pivotal sesquiterpene derived primarily from *Artemisia annua L. *, functions as a critical precursor for the semi-synthesis of artemisinin, an active pharmaceutical ingredient essential in antimalarial drugs. The market's expansion is robustly supported by several key drivers, including the persistent global burden of malaria, which sustains the demand for artemisinin-based combination therapies, and continuous advancements in biotechnological production methods like microbial fermentation, offering enhanced supply chain reliability and cost predictability. Furthermore, increasing investments in research and development exploring diverse therapeutic applications beyond malaria also contribute to market growth.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 521.9 Million
Market Size 2030
USD 664.57 Million
CAGR 2025-2030
4.11%
Fastest Growing Segment
Antimalarial Tablets
Largest Market
Middle East & Africa
Key Market Drivers
The global artemisinic acid market is significantly influenced by the persistent burden of malaria worldwide and continuous advancements in biotechnological production methods. The enduring health crisis of malaria consistently drives demand for artemisinin-based combination therapies, which in turn elevates the need for artemisinic acid as a crucial precursor. The crisis necessitates a steady supply of effective antimalarial drugs. According to the World Health Organization (WHO), in December 2024, the Malaria Report stated that global malaria cases reached an estimated 263 million in 2023, underscoring the vast and ongoing need for treatment. Simultaneously, advancements in biotechnological production methods significantly enhance supply chain reliability and cost predictability for artemisinic acid. Synthetic biology innovations, particularly engineered microbial fermentation, revolutionize manufacturing.
Key Market Challenges
The emergence of artemisinin resistance in malaria parasites poses a significant challenge to the Global Artemisinic Acid Market. This resistance directly undermines the efficacy of artemisinin-based combination therapies, which are currently pivotal for malaria treatment. As parasites develop resistance, the sustained effectiveness of these essential drugs is jeopardized, leading to reduced confidence in artemisinin as a reliable active pharmaceutical ingredient. This instability threatens the consistent demand for artemisinic acid, its key precursor.
Developing new antimalarial drugs to overcome this resistance represents a substantial financial burden on the pharmaceutical industry. According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), the estimated cost for researching and developing a new chemical or biological entity was €3,130 million (equivalent to $3,296 million in 2022 dollars) in 2022. This considerable investment, required for ongoing innovation to counteract resistance, diverts resources and increases development timelines, thereby impeding stable market growth for established precursors like artemisinic acid.
Key Market Trends
The prioritization of sustainable production processes is emerging as a critical trend within the global artemisinic acid market. This focus extends beyond mere compliance, reflecting a concerted effort across the pharmaceutical industry to minimize environmental impact and promote ethical manufacturing practices throughout the supply chain. Companies are increasingly investing in green chemistry principles, adopting renewable energy sources, and implementing waste reduction strategies to enhance their ecological footprint. According to Cytiva's 2024 Global Biopharma Sustainability Review, sustainability ranks as the number one priority for 62% of biopharma companies over the next five years, indicating a significant shift towards environmentally conscious operations. This commitment drives innovation in manufacturing techniques, promoting resource efficiency and a reduced reliance on hazardous materials in the production of key pharmaceutical precursors like artemisinic acid.
Key Market Players
Sanofi SA
KPC Pharmaceuticals, Inc
Guilin Pharmaceutical Co., Ltd
Calyx Chemicals and Pharmaceuticals Ltd.
Novartis AG
Ipca Laboratories Ltd.
Cipla Inc.
Shin Poong Pharm Co., Ltd.
Rupus Global Limited
AdvacarePharma
Report Scope:
In this report, the Global Artemisinic Acid Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Artemisinic Acid Market, By Type:
Total Synthesis
Semi synthesis
Artemisinic Acid Market, By Applications:
Antimalarial Injections
Antimalarial Tablets
Artemisinic Acid Market, By Region:
Middle East & Africa
South Africa
Saudi Arabia
UAE
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Europe
France
United Kingdom
Italy
Germany
Spain
North America
United States
Canada
Mexico
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Artemisinic Acid Market.
Available Customizations:
Global Artemisinic Acid Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Artemisinic Acid Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Total Synthesis, Semi synthesis)
5.2.2. By Applications (Antimalarial Injections, Antimalarial Tablets)
5.2.3. By Region
5.2.4. By Company (2024)
5.3. Market Map
6. North America Artemisinic Acid Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Applications
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Artemisinic Acid Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Applications
6.3.2. Canada Artemisinic Acid Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Applications
6.3.3. Mexico Artemisinic Acid Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Applications
7. Europe Artemisinic Acid Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Applications
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Artemisinic Acid Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Applications
7.3.2. France Artemisinic Acid Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Applications
7.3.3. United Kingdom Artemisinic Acid Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Applications
7.3.4. Italy Artemisinic Acid Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Applications
7.3.5. Spain Artemisinic Acid Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Applications
8. Asia Pacific Artemisinic Acid Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Applications
8.2.3. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Artemisinic Acid Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Applications
8.3.2. India Artemisinic Acid Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Applications
8.3.3. Japan Artemisinic Acid Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Applications
8.3.4. South Korea Artemisinic Acid Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Applications
8.3.5. Australia Artemisinic Acid Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Applications
9. Middle East & Africa Artemisinic Acid Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Applications
9.2.3. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Artemisinic Acid Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Applications
9.3.2. UAE Artemisinic Acid Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Applications
9.3.3. South Africa Artemisinic Acid Market Outlook
